DISCOUNT ZERTIFIKAT - EDWARDS LIFESCIENCES | Market Closed - Boerse Frankfurt Warrants 15:40:19 2024-06-21 EDT | ||
| 79.94 EUR | +0.97% |
|
| Current month | +4.91% | ||
| 1 month | +1.78% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-06-21 | 79.9 | +0.92% |
| 24-06-20 | 79.17 | +2.01% |
| 24-06-19 | 77.61 | -0.45% |
| 24-06-18 | 77.96 | +1.55% |
| 24-06-17 | 76.77 | -0.80% |
Real-time Boerse Frankfurt Warrants
Last update June 21, 2024 at 03:40 pm
More quotesStatic data
| Product type | Discount-Zertifikate |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
BNP Paribas
|
| WKN | PC63K0 |
| ISIN | DE000PC63K01 |
| Date issued | 2024-03-22 |
| Maturity | 2025-12-19 (546 Days) |
| Parity | 1 : 1 |
| Emission price | 78.97 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 81.25 € |
|---|---|
| Lowest since issue | 75.13 € |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
90.9
USD
Average target price
96.05
USD
Spread / Average Target
+5.67%
- Stock Market
- Certificates
- Certificat
